The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop sialic acid Lectenz®.
The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop sialic acid Lectenz®.